Metropolis Healthcare Ltd
NSE:METROPOLIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
IN |
Balance Sheet
Balance Sheet Decomposition
Metropolis Healthcare Ltd
Metropolis Healthcare Ltd
Balance Sheet
Metropolis Healthcare Ltd
| Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
336
|
405
|
601
|
514
|
1 072
|
3 866
|
670
|
693
|
630
|
395
|
|
| Cash |
336
|
405
|
601
|
463
|
1 015
|
1 008
|
479
|
494
|
570
|
366
|
|
| Cash Equivalents |
0
|
0
|
0
|
51
|
57
|
2 858
|
191
|
199
|
60
|
30
|
|
| Short-Term Investments |
948
|
1 346
|
1 018
|
599
|
1 159
|
414
|
1 137
|
369
|
613
|
787
|
|
| Total Receivables |
777
|
900
|
1 118
|
1 604
|
1 416
|
1 337
|
1 484
|
1 317
|
1 359
|
1 579
|
|
| Accounts Receivables |
702
|
803
|
1 007
|
1 375
|
1 304
|
1 235
|
1 368
|
1 219
|
1 265
|
1 489
|
|
| Other Receivables |
75
|
97
|
111
|
229
|
113
|
102
|
116
|
98
|
94
|
90
|
|
| Inventory |
156
|
141
|
212
|
261
|
244
|
442
|
547
|
499
|
428
|
541
|
|
| Other Current Assets |
36
|
59
|
57
|
70
|
80
|
25
|
94
|
149
|
128
|
156
|
|
| Total Current Assets |
2 253
|
2 851
|
3 006
|
3 047
|
3 971
|
6 085
|
3 931
|
3 027
|
3 158
|
3 459
|
|
| PP&E Net |
1 062
|
1 061
|
1 123
|
1 167
|
1 809
|
2 183
|
2 487
|
3 106
|
3 360
|
3 605
|
|
| PP&E Gross |
1 062
|
1 061
|
1 123
|
1 167
|
1 809
|
2 183
|
2 487
|
3 106
|
3 360
|
3 605
|
|
| Accumulated Depreciation |
158
|
166
|
333
|
494
|
563
|
743
|
1 011
|
1 281
|
1 429
|
1 750
|
|
| Intangible Assets |
10
|
147
|
168
|
234
|
282
|
346
|
3 613
|
3 749
|
3 863
|
4 966
|
|
| Goodwill |
351
|
825
|
784
|
786
|
904
|
903
|
4 547
|
4 547
|
4 547
|
5 899
|
|
| Note Receivable |
101
|
47
|
50
|
130
|
274
|
116
|
33
|
28
|
22
|
39
|
|
| Long-Term Investments |
72
|
100
|
101
|
24
|
31
|
19
|
18
|
19
|
59
|
70
|
|
| Other Long-Term Assets |
111
|
120
|
73
|
140
|
253
|
394
|
674
|
540
|
541
|
636
|
|
| Other Assets |
351
|
825
|
784
|
786
|
904
|
903
|
4 547
|
4 547
|
4 547
|
5 899
|
|
| Total Assets |
3 959
N/A
|
5 152
+30%
|
5 303
+3%
|
5 526
+4%
|
7 522
+36%
|
10 044
+34%
|
15 303
+52%
|
15 016
-2%
|
15 551
+4%
|
18 673
+20%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
328
|
359
|
353
|
429
|
850
|
1 106
|
1 032
|
941
|
994
|
1 259
|
|
| Accrued Liabilities |
45
|
59
|
101
|
106
|
0
|
200
|
217
|
207
|
211
|
198
|
|
| Short-Term Debt |
4
|
4
|
4
|
176
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2
|
209
|
333
|
1 373
|
1 123
|
780
|
921
|
|
| Other Current Liabilities |
532
|
1 096
|
449
|
533
|
635
|
400
|
394
|
379
|
473
|
566
|
|
| Total Current Liabilities |
910
|
1 519
|
906
|
1 245
|
1 695
|
2 040
|
3 015
|
2 650
|
2 459
|
2 943
|
|
| Long-Term Debt |
5
|
4
|
2
|
0
|
458
|
789
|
2 413
|
1 541
|
1 191
|
1 121
|
|
| Deferred Income Tax |
79
|
70
|
44
|
29
|
17
|
42
|
867
|
782
|
751
|
995
|
|
| Minority Interest |
152
|
210
|
144
|
14
|
17
|
15
|
20
|
25
|
31
|
37
|
|
| Other Liabilities |
27
|
118
|
60
|
53
|
101
|
93
|
126
|
136
|
158
|
268
|
|
| Total Liabilities |
1 172
N/A
|
1 920
+64%
|
1 156
-40%
|
1 341
+16%
|
2 287
+71%
|
2 978
+30%
|
6 441
+116%
|
5 134
-20%
|
4 589
-11%
|
5 364
+17%
|
|
| Equity | |||||||||||
| Common Stock |
95
|
95
|
95
|
100
|
101
|
102
|
102
|
102
|
102
|
104
|
|
| Retained Earnings |
2 124
|
2 549
|
3 455
|
3 191
|
3 931
|
5 405
|
7 182
|
8 188
|
9 259
|
10 697
|
|
| Additional Paid In Capital |
583
|
583
|
583
|
871
|
1 189
|
1 531
|
1 564
|
1 566
|
1 566
|
2 462
|
|
| Other Equity |
15
|
4
|
14
|
23
|
14
|
28
|
13
|
26
|
34
|
47
|
|
| Total Equity |
2 787
N/A
|
3 232
+16%
|
4 148
+28%
|
4 185
+1%
|
5 235
+25%
|
7 066
+35%
|
8 862
+25%
|
9 882
+12%
|
10 962
+11%
|
13 310
+21%
|
|
| Total Liabilities & Equity |
3 959
N/A
|
5 152
+30%
|
5 303
+3%
|
5 526
+4%
|
7 522
+36%
|
10 044
+34%
|
15 303
+52%
|
15 016
-2%
|
15 551
+4%
|
18 673
+20%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
50
|
50
|
50
|
50
|
51
|
51
|
51
|
51
|
51
|
52
|
|